Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The share is getting closer to its long-term support in weekly data, at USD 127.27, which offers good timing for buyers.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
Weaknesses
  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company's earnings releases usually do not meet expectations.
  • With an enterprise value anticipated at 4.26 times the sales for the current fiscal year, the company turns out to be overvalued.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
JOHNSON & JOHNSON1.34%341 878
ROCHE HOLDING LTD.12.28%234 825
MERCK AND COMPANY7.36%210 028
PFIZER-15.62%203 709
NOVARTIS16.65%198 073
AMGEN-0.30%116 390
NOVO NORDISK AS13.01%116 389
ASTRAZENECA15.66%110 661
SANOFI4.53%108 909
ABBVIE-23.44%104 351
ELI LILLY AND COMPANY-4.83%100 817
GLAXOSMITHKLINE9.12%99 990
BRISTOL-MYERS SQUIBB COMPAN..-4.83%80 921
CELGENE CORPORATION53.50%69 726
BAYER AG12.07%69 606
TAKEDA PHARMACEUTICAL CO LT..4.59%54 608
More Results
Financials (USD)
Sales 2019 81 594 M
EBIT 2019 25 389 M
Net income 2019 18 319 M
Debt 2019 5 892 M
Yield 2019 2,90%
P/E ratio 2019 19,3x
P/E ratio 2020 17,1x
EV / Sales2019 4,26x
EV / Sales2020 4,00x
Capitalization 342 B
Upcoming event on JOHNSON & JOHNSON
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes